Opportunities and challenges with new drug modalities
29 November 2023
Opportunities and challenges with new drug modalities
Super Session 4
New drug modalities such as cell and gene therapies and mRNA have shown great potential to cure patients suffering from cancer, infections, and other diseases. The Nordics is a home for several biotech companies developing groundbreaking novel therapies. This session explores what the main opportunities and challenges are related to development, manufacturing, regulatory aspects, and clinical use of new drug modalities.
Moderator(s): Dr. Anders Holmén - VP & Head of Pharmaceutical Sciences, BioPharmaceuticals R&D , AstraZeneca Dr. Ulrica Sehlstedt - Global Practice Leader Healthcare and Life Sciences, Arthur D. Little
Speaker(s):